Biopharma Job Market Report Q2 2026: Hiring Rebounds, Layoffs Ease, AI and R&D Talent in High Demand

The Biopharma Job Market Report Q2 2026 highlights a rebound in hiring activity and a notable decline in layoffs compared to prior quarters.

Job postings in the biopharma sector increased in Q2 2026, with sustained demand for R&D roles and emerging demand for specialized talent in regulatory affairs, data science, AI, and digital health.

Biopharma hiring in 2026 is characterized by targeted, selective recruitment rather than broad headcount expansion, with a focus on pipeline stability and de-risking assets.

Layoffs in biopharma dropped sharply in Q2 2026, with only 17 companies reporting cuts versus 33 in Q1 and far fewer than in Q2 2025, indicating reduced pressure on the workforce.

Key functions seeing the strongest hiring momentum include research and development, clinical operations, regulatory affairs, manufacturing, quality, and AI/data science roles, especially around GLP-1, oncology, cell and gene therapy, and biologics.